Intra-tumoural bromelain and N-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial
Br J Surg
.
2024 Mar 2;111(3):znae045.
doi: 10.1093/bjs/znae045.
Authors
Lidia Rodríguez-Ortiz
1
2
3
,
Mari C Vázquez-Borrego
2
3
,
Florina I Bura
2
3
,
Melissa Granados-Rodríguez
2
3
,
Francisca Valenzuela-Molina
1
2
,
Blanca Rufián-Andújar
1
2
,
Ana Martínez-López
2
4
,
Rosa Ortega-Salas
2
4
,
Juan José Espejo-Herrero
5
,
Antonio Romero-Ruiz
2
3
,
Álvaro Arjona-Sánchez
1
2
Affiliations
1
Unit of Surgical Oncology, Department of Surgery, Reina Sofía University Hospital, Córdoba, Spain.
2
GE09 Research in Peritoneal and Retroperitoneal Oncological Surgery, Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
3
Department of Biochemistry and Molecular Biology, University of Córdoba, Córdoba, Spain.
4
Unit of Pathology, Reina Sofia University Hospital, Córdoba, Spain.
5
Unit of Radiology, Reina Sofia University Hospital, Cordoba, Spain.
PMID:
38477594
DOI:
10.1093/bjs/znae045
No abstract available
Publication types
Clinical Trial, Phase II
Clinical Trial, Phase I
MeSH terms
Acetylcysteine
Adenocarcinoma, Mucinous*
Bromelains
Humans
Peritoneal Neoplasms*
Pseudomyxoma Peritonei*
Substances
Acetylcysteine
Bromelains
Grants and funding
PI-0064-2020/Foundation for Progress and Health of the Andalusian Regional Government